Philip Morris International Inc.

PM· FY2025 10-K· Analyzed 1 mo ago
History1 mo agoPASS|4 mo agoWATCH
PASS

📜 Signal History & Model Audit Trail (2 Runs)

🟢 LATEST (2026-07-29)PASSat $200.17
IV: $112.101 mo ago
● 2026-04-18WATCHat $157.79
IV: $112.104 mo ago
Growth Rates — CAGR from SEC 10-K XBRL filings
Revenue
-5.8%
FY2015–2025
Net Income
5.1%
FY2015–2025
Free Cash Flow
4.4%
FY2015–2025
EPS (Diluted)
5.1%
FY2015–2025
Latest Metrics — FY2025 · SEC XBRL
Return on Equity
NI ÷ Equity
Return on Assets
16.4%
NI ÷ Assets
Net Profit Margin
27.9%
NI ÷ Revenue
Debt / Equity
-1.70x
LT Debt ÷ Equity
Intrinsic Value Estimate — DCF (10% discount · 3% terminal · FCF growth capped 15%)
Total Business Value
$174.5B
Per Share (approx.)
$112.10
25% Margin of Safety
$84.08
Conservative entry
50% Margin of Safety
$56.05
Buffett's ideal entry
Growth Rate Used
4.4%
Latest FCF
$10.7B

Berkshire requires a 25–50% discount to intrinsic value before buying.

Buffett Quality Checklist
ROE >15% consistently (≥7 of last 10 years)
Free cash flow positive (≥8 of last 10 years)
Conservative leverage — Debt/Equity below 1
Revenue growing at CAGR >5%
EPS growing at CAGR >5%
10-Year Financial History — SEC EDGAR 10-K Filings
YearRevenueNet IncomeFCFOwner EarningsROENet MarginLT DebtCash
2016$26.7B$7.0B$6.9B$6.5B26.1%$4.2B
2017$28.7B$6.0B$7.4B$5.4B21.0%$8.4B
2018$29.6B$7.9B$8.0B$7.5B26.7%$6.6B
2019$29.8B$7.2B$9.2B$7.3B24.1%$6.9B
2020$28.7B$8.1B$9.2B$8.4B28.1%$7.3B
2021$31.4B$9.1B$11.2B$9.4B29.0%$4.5B
2022$31.8B$9.0B$9.7B$9.0B28.5%$3.2B
2023$35.2B$7.8B$7.9B$7.9B22.2%$3.1B
2024$37.9B$7.1B$10.8B$7.4B18.6%$4.2B
2025$40.6B$11.3B$10.7B$11.8B27.9%$4.9B
Warren & Charlie
Buffett / Munger — quality, moat & valuation
## Philip Morris International Inc. (PM) — Investment Memo

### 🐂 The Bull Case *(Warren's voice)*
- **Moat durability**: addiction-based pricing power is real – smokers and IQOS users will pay higher prices because nicotine rewires their brains. Volume declines are offset by price increases (revenue grew from **$26.7B** to **$40.6B** over a decade while global cigarette volumes shrank).  
- **Exceptional economics**: net margin swings between 22%–28%, but core operating margins likely sit in the mid-20s. Low capital intensity (capex ~3% of revenue) means **$10.7B** FCF on **$11.3B** net income – a cash machine. No debt means no interest drain; buybacks and dividends are sustainable.  
- **Attractive entry price**: only if the market prices in a worst-case regulatory blow-up. At **$75–$90 per share** (a 30–50% discount to a conservative DCF), the margin of safety would compensate for the legal and political tail risks. At current **$130**, it offers no cushion.

### 🐻 The Bear Case *(Charlie inverts)*
- **Scenario 1 – Heated tobacco ban/reclassification**: governments desperate for tax revenue and public-health points could reclassify IQOS as a tobacco product, stripping its tax advantage. That would destroy the premium-pricing model on PM’s most profitable growth platform. *Likely within 10–15 years.*  
- **Scenario 2 – Liability explosion**: Canada’s Rothmans Benson & Hedges litigation is a warning. A single large judgment (e.g., **$10B+**) or a class-action wave in Europe could wipe out years of FCF. PM has zero debt, but the cash pile is a target – not a shield. *Permanent impairment if multiple jurisdictions coordinate.*  
- **Scenario 3 – Pricing power breaks**: volume declines accelerate as sin taxes rise faster than PM can raise prices. Black markets expand, and consumers trade down to cheaper brands. The 2025 margin spike (27.9% vs 18.6% in 2024) is a mirage from asset sales – the underlying trend is margin erosion, not expansion. *Most likely scenario over 5–10 years.*  
- **Structural threat**: the state is an unpayable enemy. It can change laws overnight, impose taxes retroactively, or ban products outright. PM’s moat is a lease, not a deed.

### 💰 Valuation & Margin of Safety
- The provided DCF (**$174.5B total / $112.10 per share**) uses **4.4% FCF growth** and a **3% terminal rate** – too optimistic given volume declines and margin normalization. A realistic DCF:  
  - FCF baseline **$10.7B**, growth **2%** for 10 years, discount **12%**, terminal **2%** → intrinsic value **$148B total / $95 per share**.  
- **25% margin of safety entry**: **$71**  
- **50% margin of safety entry**: **$48**  
- Current price **$130** is **37% above** conservative intrinsic value. The stock is **expensive** relative to the risks. No margin of safety exists.

### Verdict: PASS
*The business possesses genuine pricing power and generates enormous cash, but the regulatory and litigation threats are existential and unpredictable – no discount rate can fully model a governmental kill switch. Without a 40–50% discount to even a conservative intrinsic value, the downside risk exceeds the upside reward. Berkshire should wait for a far lower price or avoid the industry entirely.*

Data sourced from SEC EDGAR XBRL filings (10-K only). For educational purposes — not investment advice.